BC-CfE applauds France’s adoption of HIV treatment as prevention strategy

France has announced the adoption of the Treatment as Prevention (TasP) strategy, as pioneered by the BC Centre for Excellence in HIV/AIDS (BC-CfE), to combat HIV and AIDS.

France becomes the latest country to adopt TasP, originally endorsed by the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2010. Since then, in 2011 China became the first nation to adopt the strategy, and the U.S. identified TasP as a key strategy to achieve an AIDS-free generation in 2012. More recently, in July 2013, the World Health Organization fully incorporated TasP in the new Global HIV Treatment Guidelines.

Read the full story

Leave a Reply

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below